New partnership enhances contraceptive access for UK women

Evaro, the NHS-licensed embedded healthcare platform, has announced a groundbreaking collaboration with Clue, a leading period and cycle tracker trusted by over 100 million users globally. This partnership aims to seamlessly incorporate NHS-funded contraception services directly into Clue's app, revolutionising access for UK women.

This initiative represents the first instance of a major cycle-tracking platform integrating prescription healthcare services within the UK. Given the country's ongoing emergency contraception crisis, the timing couldn't be more critical. Recent data from 2023 highlights the UK's leading global search volumes for emergency contraception, with nearly half of UK women encountering significant barriers to accessing contraception. Alarmingly, one in 20 patients faces up to a four-week wait to consult with a GP.

Launching amidst heightened governmental focus on women's health and digital transformation within the NHS, this integration marries Clue's vast user base with Evaro's comprehensive healthcare platform. Leveraging this union, users can transition effortlessly from monitoring their cycle to ordering NHS-funded contraception through Evaro's embedded pharmacy infrastructure. This service offers free delivery nationwide, presenting a remote alternative to existing postcode-limited digital NHS services.

Dr. Thuria Wenbar, CEO and co-founder of Evaro, argues that nearly half of UK women lack access to basic contraception, a systemic issue solvable through technology. Dr. Wenbar likens this innovation to a "banking moment" for healthcare, underscoring the necessity for a streamlined, accessible service that mirrors modern online banking conveniences.

Rhiannon White, CEO of Clue, echoes this sentiment, highlighting their mission to empower individuals through understanding their bodies. White envisions this partnership as a pivotal step in transformative menstrual and reproductive health education and access on a global scale.

The service showcases the efficacy of asynchronous healthcare. Here's how it works:

• Users complete a brief digital consultation via the Clue app.
• Pertinent prescriptions are evaluated and approved by Evaro's certified clinicians.
• Eligible UK patients gain access to 40 different NHS-funded oral contraceptive options.
• These medications are then discreetly dispatched from Evaro's GPhC-registered pharmacy with next-day delivery.

This collaboration heralds a new era of embedded healthcare, transforming consumer brands into healthcare access points via Evaro's full-stack solution, integrated through a singular line of code. The partnership not only resolves pressing accessibility issues but concurrently affords women greater agency over their reproductive health.